BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26972343)

  • 1. Posttransplant lymphoproliferative disease and survival in adult heart transplant recipients.
    Hayes D; Tumin D; Foraker RE; Tobias JD
    J Cardiol; 2017 Jan; 69(1):144-148. PubMed ID: 26972343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation.
    Hayes D; Breuer CK; Horwitz EM; Yates AR; Tobias JD; Shinoka T
    Pediatr Cardiol; 2015 Dec; 36(8):1748-53. PubMed ID: 26187515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
    Manlhiot C; Pollock-Barziv SM; Holmes C; Weitzman S; Allen U; Clarizia NA; Ngan BY; McCrindle BW; Dipchand AI
    J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: Analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database.
    Karamlou T; Welke KF; McMullan DM; Cohen GA; Gelow J; Tibayan FA; Mudd JM; Slater MS; Song HK
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):456-461.e1. PubMed ID: 24183335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
    Aull MJ; Buell JF; Trofe J; First MR; Alloway RR; Hanaway MJ; Wagoner L; Gross TG; Beebe T; Woodle ES
    Transplantation; 2004 Dec; 78(11):1676-82. PubMed ID: 15591959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
    Kang W; Sampaio MS; Huang E; Bunnapradist S
    Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation.
    Kim IC; Kim SH; Youn JC; Kim D; Lee S; Kim H; Kim JJ; Jung MH; Rossano JW; Cherikh WS; Kobashigawa JA; Stehlik J
    JACC Heart Fail; 2024 Feb; 12(2):395-405. PubMed ID: 38326002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Evaluation of Post-transplant Lymphoproliferative Disorders in Paediatric Heart Transplantation in Sao Paulo, Brazil.
    Arshad A; Azeka E; Barbar S; Marcondes R; Siqueira A; Benvenuti L; Miura N; Jatene M; Filho VO
    Pediatr Cardiol; 2019 Dec; 40(8):1655-1662. PubMed ID: 31506731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
    Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ
    J Heart Lung Transplant; 2015 Nov; 34(11):1406-14. PubMed ID: 26279197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
    Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorder after pancreas transplantation: a United Network for Organ Sharing database analysis.
    Jackson K; Ruppert K; Shapiro R
    Clin Transplant; 2013; 27(6):888-94. PubMed ID: 24118329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
    Khedmat H; Taheri S
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
    Rosenberg AS; Ruthazer R; Paulus JK; Kent DM; Evens AM; Klein AK
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):684-692.e3. PubMed ID: 27771291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
    Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.
    Wudhikarn K; Holman CJ; Linan M; Blaes AH; Dunitz JM; Hertz ME; Peterson BA
    Clin Transplant; 2011; 25(5):705-13. PubMed ID: 21077949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
    Lowery EM; Adams W; Grim SA; Clark NM; Edwards L; Layden JE
    J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does recipient work status pre-transplant affect post-heart transplant survival? A United Network for Organ Sharing database review.
    Ravi Y; Lella SK; Copeland LA; Zolfaghari K; Grady K; Emani S; Sai-Sudhakar CB
    J Heart Lung Transplant; 2018 May; 37(5):604-610. PubMed ID: 29482932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.